Viewing Study NCT00283933


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-01-22 @ 12:24 PM
Study NCT ID: NCT00283933
Status: COMPLETED
Last Update Posted: 2018-09-07
First Post: 2006-01-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease
Sponsor: Amicus Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fabry Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Amicus Therapeutics View
None AT1001 View
None Galafold View
None Migalastat View
None Substrate View